HHMI
AVY icon

Howard Hughes Medical Institute’s Avery Dennison AVY Stock Holding History

Howard Hughes Medical Institute’s Portfolio AVY Stock Details AVY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed -$3.09K – 72
2025
Q4 		$3.09K Hold
17
– – ﹤0.01% 425
2025
Q3 		$2.76K Hold
17
– – ﹤0.01% 433
2025
Q2 		$2.98K Buy
+17
New +$2.98K ﹤0.01% 423

Other funds holding AVY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Howard Hughes Medical Institute's AVY Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Avery Dennison (AVY) in Q1 2026, closing a stake of 17 shares — an estimated $3.09K sold.

Howard Hughes Medical Institute first reported a position in AVY in Q2 2025 and held it in 3 quarters. The position peaked at $3.09K in Q4 2025. 791 funds tracked by Wall St. Rank hold AVY as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Avery Dennison position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 17 Avery Dennison shares in Q1 2026, an estimated $3.09K.
  • Howard Hughes Medical Institute first reported a position in Avery Dennison in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Avery Dennison position peaked at $3.09K in Q4 2025.
  • 791 funds tracked by Wall St. Rank held Avery Dennison as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.